Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer
March 28, 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the...
UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer
February 24, 2022 16:09 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on...
Isracann Signs LOI to Acquire Natural Health Medicine Developer
February 23, 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on...
Isracann Advises on Recent Activities and 2022 Outlook
February 09, 2022 08:30 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...
Isracann Appoints Operational Expert Phil Floucault as CEO and Grants Options
October 20, 2021 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...
Isracann Appoints Experienced Farm Manager and Updates Israeli Cannabis Operations
August 31, 2021 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...
Isracann Receives Foreign Owners License and Updates Israeli Cannabis Operations
April 21, 2021 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...
Isracann Applauds Expanded Cannabis Accessibility
March 18, 2021 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”), an Israel-based company focused on...
Isracann Signs Cannabis Importation LOI with Major Israeli Manufacturer
March 03, 2021 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...
Isracann Prepares for Recreational Cannabis Opportunity in Israel
February 25, 2021 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...